Now I'd like to turn the conference over to Fennec's Chief Financial Officer, Robert Andrade. We are pleased to host Fennec Pharmaceuticals' Second Quarter 2026 Earnings Conference Call today, during which we will review our financial results as well as provide a general business update. Joining me from Fennec this morning is our Chief Executive Officer and Board member, Jeff Hackman; our Chief Commercial Officer, Terry Evans; and our Chief Medical Officer, Dr. Pierre Sayad. I am also pleased to welcome our Chief Strategy Officer, Christy Cioffi, who is joining our earnings call for the first time. Christy has more than 2 decades of leadership experience spanning commercial strategy, brand building and organizational development, including nearly 15 years of expertise leading award-winning commercialization and launch strategies across the product life cycle.